AnteoTech Limited (ASX:ADO)
Australia · Delayed Price · Currency is AUD 0.0240
+0.0020 (9.09%)
Oct 3, 2025, 4:10 PM AEST
AnteoTech Revenue
In the fiscal year ending June 30, 2025, AnteoTech had annual revenue of 968.88K AUD with 110.44% growth. AnteoTech had revenue of -2.19M in the half year ending June 30, 2025, a decrease of -30.40%.
Revenue
968.88K
Revenue Growth
+110.44%
P/S Ratio
67.56
Revenue / Employee
9.79K
Employees
99
Market Cap
65.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 968.88K | 508.48K | 110.44% |
| Jun 30, 2024 | 460.40K | 94.67K | 25.89% |
| Jun 30, 2023 | 365.72K | -395.15K | -51.93% |
| Jun 30, 2022 | 760.88K | -137.19K | -15.28% |
| Jun 30, 2021 | 898.07K | -367.90K | -29.06% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Telix Pharmaceuticals | 1.01B |
| Ansell | 3.06B |
| Mesoblast | 26.23M |
AnteoTech News
- 7 months ago - AnteoTech Ltd (ASX:ADO) (H1 2025) Earnings Call Highlights: Transition to Market-Driven Success - GuruFocus
- 7 months ago - Half Year 2025 Anteotech Ltd Earnings Call Transcript - GuruFocus